Compound 4. Compound 3 (4.0 mmol, 1.65 g) was dissolved in dichloromethane (10 mL). After addition of trifluoroacetic acid (3 mL), the mixture was stirred at room temperature for 2 h. The solvent was evaporated, and the residue was obtained (1.2 g, 95% yield) and directly used without further purification.
Compound 6. Compound 4 (0.3 mmol, 93 mg) was dissolved in a combined solvent of HCl (0.3 mL), AcOH (3.0 mL), and CH 2 Cl 2 (0.6 mL). After cooled to 0 °C, sodium nitrite (0.6 mmol, 41 mg) was added slowly while the mixture was constantly stirred.
The mixture was then stirred for additional 2 h at room temperature. A concentrated NaHCO 3 solution was added to adjust the solution pH to neutral before the mixture was extracted with CH 2 Cl 2 . The organic layer was dried with Na 2 SO 4 , filtered, and evaporated under reduced pressure to afford the crude product, which was purified by column chromatography on silica gel (dichloromethane/ methanol, 10:1 v/v) to obtain a light yellow solid (77 mg, 75% yield 89, 164.21, 163.57, 162.57, 157.55, 152.40, S5 149.86, 148.02, 134.63, 131.12, 131.06, 129.86, 126.27, 124.18, 122.50, 120.01, 110.27, 109.82, 109.32, 108.30, 104.03, 96.45, 45.09, 43.48, 39.33, 38.61, 30.86, 20.43, 13.94, 12.45 88, 163.63, 163.42, 162.53, 157.53, 152.31, 148.06, 142.96, 141.55, 132.11, 131.12, 129.46, 129.12, 128.19, 127.98, 125.48, 123.91, 123.13, 122.96, 109.97, 108.42, 96.42, 47.60, 45.16, 39.69, 38.20, 28.49, 20.31, 13.53, 12.38 7. Absorption and emission spectra 
EPR analysis using PTIO

Quantum yield
Fluorescence quantum yields of CNNO and CN were determined by using quinine sulphate (Φ f = 0.54 in 0.1 M H 2 SO 4 ) as a fluorescence standard. The quantum yield was calculated using the following equation:
Where Φ F is the fluorescence quantum yield, A is the absorbance at the excitation wavelength, F is the area under the corrected emission curve, and n is the refractive index of the solvents used. Subscripts S and X refer to the standard and to the unknown, respectively. For the synthesized dyes, the excitation wavelength was at 408 nm while keeping the absorption below 0.05. 
Test of photostability
MTT assay
Hela cells were seeded into a 96-well microtiter plate at 37 °C in a 5% CO 2 /95% air incubator for 24 h. The cells were incubated for an additional 24 h with different concentrations of tested compounds (0, 10, 20, 50, 100, and 200 μΜ), respectively.
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Then the cells were washed with PBS three times. Subsequently, MTT solution (200 µL, 0.5 mg/mL) was added to each well and the cells were incubated at 37 °C. After 4 h, the remaining MTT was removed, and the formazan crystals were dissolved in 200 µL of DMSO with gentle agitation for 5 min. The absorbance at 490 nm was measured using a TRITURUS microplate reader.
Fig. S6 MTT assay of Hela cells with different concentrations of CNNO (a) and its photodecomposed product CN (b).
Spatial controlling NO release in live cells
Hela cells were cultured in high glucose DMEM supplemented with 10% fetal bovine serum, 1% penicillin, and 1% streptomycin at 37 °C in a 5% CO 2 ⁄95% air incubator MCO-5AC (SANYO, Tokyo, Japan). One day before imaging, the cells were detached and were replanted on glass-bottomed dishes. For NO release, the cells were incubated with 10 μΜ CNNO for 15 min before being washed three times with PBS. Then for one-photon irradiation, the cells were subjected to a CEL-HXF300
Xenon lamp with power of 15 mW/cm 2 for 5 min. For two-photon irradiation, a region of interest of the cells were subjected to the confocal fluorescence microscopy (Zeiss LSM 880) and bleached with an 800 nm laser (20 mW) for 2 min. After irradiation, the images were captured with 405 nm excitation or 840 nm excitation. S11 
Temporal modulation of vasodilation by CNNO
All animal experiments were in strict accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. A strip of mouse thoracic aorta was placed and fixed in one chamber of 620M Multi Myograph System, which was filled with PSS buffer (4.7 mM KCl, 119 mM NaCl, 25 mM NaHCO 3 , 2.5 mM CaCl 2 , 1.18 mM KH 2 PO 4 , 1.17 mM MgSO 4 , 5.5 mM glucose, and 0.03 mM EDTA, pH 7.4) at 37 °C. Then the strip was pretreated with 10 μM L-NAME, and then incubated in KPSS buffer (123.7 mM KCl, 25 mM NaHCO 3 , 2.5 mM CaCl 2 , S13 1.18 mM KH 2 PO 4 , 1.17 mM MgSO 4 , 5.5 mM glucose, and 0.03 mM EDTA, pH 7.4).
After equilibration, 10 μM CNNO was added and the chamber was irradiated with 365 nm light (15 mW/cm 2 ) for 60 s and 30 s in turn. As the negative control, another strip of aorta was irradiated for 90 s without treatment of CNNO.
13. NMR and HRMS spectra on an Agilent 1260 Infinity instrument equipped with an Agilent 1260 Infinity Diode array detector VL (G1315D). Separation was performed on a Shim-pack CLC-ODS column (250 × 4.6 mm, 5 μm). The mobile phase was water/acetonitrile (0.1% formic acid) 5:95, and the flow rate was 0.5 mL/min. The detection wavelengths were set at 254, 345, and 455 nm, respectively. The retention times of CNNO and CN were 8.14 and 9.06 min respectively, indicating the huge difficulty to completely remove CN from CNNO. According to the HPLC results, we estimate that the purity of CNNO is ca. 95%, and the main impurity in it is the raw material CN which is also the photolytic product of CNNO.
